Teva and Kowa form generic-drug venture for Japan market

TEL AVIV (MarketWatch) — Teva Pharmaceutical Industries Ltd., Jerusalem, and Kowa Co., the Tokyo conglomerate, definitively agreed to form a 50-50 generic-pharmaceutical company in Japan. In a statement on Wednesday, the companies said Teva-Kowa Pharma Co. will leverage its parents’ respective marketing, research-and-development, manufacturing and distribution capabilities to supply generics to the Japanese market and reach sales of $1 billion in 2015. The companies said the venture will be up and running in 2009.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Original post by Forextvblog

This entry was posted on Tuesday, September 23rd, 2008 at 11:21 pm and is filed under Daily Forex Analysis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.